539 related articles for article (PubMed ID: 10566641)
1. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.
Diamanti-Kandarakis E; Kouli CR; Bergiele AT; Filandra FA; Tsianateli TC; Spina GG; Zapanti ED; Bartzis MI
J Clin Endocrinol Metab; 1999 Nov; 84(11):4006-11. PubMed ID: 10566641
[TBL] [Abstract][Full Text] [Related]
2. Psychological Distress Is More Prevalent in Fertile Age and Premenopausal Women With PCOS Symptoms: 15-Year Follow-Up.
Karjula S; Morin-Papunen L; Auvinen J; Ruokonen A; Puukka K; Franks S; Järvelin MR; Tapanainen JS; Jokelainen J; Miettunen J; Piltonen TT
J Clin Endocrinol Metab; 2017 Jun; 102(6):1861-1869. PubMed ID: 28323926
[TBL] [Abstract][Full Text] [Related]
3. Herbal medicine for the management of polycystic ovary syndrome (PCOS) and associated oligo/amenorrhoea and hyperandrogenism; a review of the laboratory evidence for effects with corroborative clinical findings.
Arentz S; Abbott JA; Smith CA; Bensoussan A
BMC Complement Altern Med; 2014 Dec; 14():511. PubMed ID: 25524718
[TBL] [Abstract][Full Text] [Related]
4. Is There a Difference in Hirsutism Score in Adolescents with Polycystic Ovary Syndrome on the Basis of Ethnicity and Race?
Badr F; Chattha AJ
J Pediatr Adolesc Gynecol; 2024 Jun; 37(3):348-352. PubMed ID: 38151058
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of polycystic ovary syndrome and related disorders in mexican women.
Moran C; Tena G; Moran S; Ruiz P; Reyna R; Duque X
Gynecol Obstet Invest; 2010; 69(4):274-280. PubMed ID: 20110726
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Response of Hirsutism and Other Hyperandrogenic Symptoms to Combination Therapy in Polycystic Ovary Syndrome.
Ezeh U; Huang A; Landay M; Azziz R
J Womens Health (Larchmt); 2018 Jul; 27(7):892-902. PubMed ID: 29878857
[TBL] [Abstract][Full Text] [Related]
7. Association of Self-Reported Polycystic Ovary Syndrome, Obesity, and Weight Gain From Adolescence to Adulthood With Hypertensive Disorders of Pregnancy: A Community-Based Approach.
Rantakallio JSS; Nevalainen JE; West SI; Ollila MM; Puukka K; Bloigu AH; Järvelin MR; Tapanainen JS; Franks S; Dunkel L; Piltonen TT; Vääräsmäki MS; Morin-Papunen LC
Hypertension; 2021 Mar; 77(3):1010-1019. PubMed ID: 33517680
[TBL] [Abstract][Full Text] [Related]
8. The prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome in treatment-naïve transgender people assigned female at birth.
Oğuz SH; Boyraz BS; Ertürk B; Yıldız BO
Endocrine; 2024 Apr; 84(1):287-292. PubMed ID: 38141060
[TBL] [Abstract][Full Text] [Related]
9. Genetic, hormonal and metabolic aspects of PCOS: an update.
De Leo V; Musacchio MC; Cappelli V; Massaro MG; Morgante G; Petraglia F
Reprod Biol Endocrinol; 2016 Jul; 14(1):38. PubMed ID: 27423183
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive evaluation of disparities in cardiometabolic and reproductive risk between Hispanic and White women with polycystic ovary syndrome in the United States: a systematic review and meta-analysis.
Kazemi M; Kim JY; Wan C; Xiong JD; Parry SA; Azziz R; Lujan ME
Am J Obstet Gynecol; 2022 Feb; 226(2):187-204.e15. PubMed ID: 34384776
[TBL] [Abstract][Full Text] [Related]
11. Hirsutism in Saudi females of reproductive age: a hospital-based study.
Al-Ruhaily AD; Malabu UH; Sulimani RA
Ann Saudi Med; 2008; 28(1):28-32. PubMed ID: 18299651
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of muscle and bone composition and function in aging women with polycystic ovary syndrome.
Çelik Eroğlu B; Karaçoban L; Idılman IS; Korkusuz F; Yıldız BO
Maturitas; 2024 Jul; 185():107982. PubMed ID: 38579578
[TBL] [Abstract][Full Text] [Related]
13. Dietary Modification for Reproductive Health in Women With Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.
Shang Y; Zhou H; He R; Lu W
Front Endocrinol (Lausanne); 2021; 12():735954. PubMed ID: 34790167
[TBL] [Abstract][Full Text] [Related]
14. Reproductive health, obesity, and cardiometabolic risk factors among Samoan women.
Maredia H; Hawley NL; Lambert-Messerlian G; Fidow U; Reupena MS; Naseri T; McGarvey ST
Am J Hum Biol; 2018 May; 30(3):e23106. PubMed ID: 29663637
[TBL] [Abstract][Full Text] [Related]
15. Effect of lifestyle modifications on anthropometric, clinical, and biochemical parameters in adolescent girls with polycystic ovary syndrome: a systematic review and meta-analysis.
Abdolahian S; Tehrani FR; Amiri M; Ghodsi D; Yarandi RB; Jafari M; Majd HA; Nahidi F
BMC Endocr Disord; 2020 May; 20(1):71. PubMed ID: 32429890
[TBL] [Abstract][Full Text] [Related]
16. The physiological basis of complementary and alternative medicines for polycystic ovary syndrome.
Raja-Khan N; Stener-Victorin E; Wu X; Legro RS
Am J Physiol Endocrinol Metab; 2011 Jul; 301(1):E1-E10. PubMed ID: 21487075
[TBL] [Abstract][Full Text] [Related]
17. Association of severity of menstrual dysfunction with cardiometabolic risk markers among women with polycystic ovary syndrome.
Li X; Yang J; Blockeel C; Lin M; Tian X; Wu H; Cao Y; Deng L; Zhou X; Xie J; Hu Y; Chen X
Acta Obstet Gynecol Scand; 2024 May; ():. PubMed ID: 38715377
[TBL] [Abstract][Full Text] [Related]
18. Correlation of HbA
Bala M; Meenakshi ; K M; Gupta A
EJIFCC; 2017 Oct; 28(3):196-204. PubMed ID: 29075170
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of metabolic syndrome in four phenotypes of PCOS and its relationship with androgenic components among Iranian women: A cross-sectional study.
Zaeemzadeh N; Sadatmahalleh SJ; Ziaei S; Kazemnejad A; Mottaghi A; Mohamadzadeh N; Movahedinejad M
Int J Reprod Biomed; 2020 Apr; 18(4):253-264. PubMed ID: 32494764
[TBL] [Abstract][Full Text] [Related]
20. Polycystic ovary syndrome throughout a woman's life.
Bellver J; Rodríguez-Tabernero L; Robles A; Muñoz E; Martínez F; Landeras J; García-Velasco J; Fontes J; Álvarez M; Álvarez C; Acevedo B;
J Assist Reprod Genet; 2018 Jan; 35(1):25-39. PubMed ID: 28951977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
